BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

valentis woodlands Pages on BioPortfolio:

BioPortfolio - Valentis
Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX 77381, USA. Ernst Schering Res Found Workshop. 2003;(43):225-44. ...
http://www.bioportfolio.com/biocorporate/10726-Valentis.html...

BioPortfolio - Valentis
VALENTIS woodlands - BioPortfolio. ... Fonsm@valentis.com. As plasmid-based gene therapy products progress through clinical . ...
http://www.bioportfolio.com/search/Valentis.html...

Results from other life science and pharmaceutical sites:

BioPortfolio - Valentis
Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX 77381, USA. Ernst Schering Res Found Workshop. 2003;(43):225-44. ...
http://www.bioportfolio.com/biocorporate/10726-Valentis.html...

Robust and prolonged gene expression from injectable polymeric ...
Calf thymus DNA (Sigma, St Louis, MO, USA), pCMV-Luc, pAP1166.157 (SEAP plasmid) or pDL 1575 (Del-1 plasmid) kindly supplied by Valentis (Woodlands, TX, ...
http://www.nature.com/gt/journal/v9/n18/full/3301786a.html...

Optimization of cationic lipid/DNA complexes for s...[J Drug ...
Valentis Inc, The Woodlands, TX 77381-4248, USA. anwerk@valentis.com. Intravenous (i.v.) administration of cationic lipid N-[( ...
http://www.ncbi.nlm.nih.gov/pubmed/10852344...

Fusogenic activity of vesicular stomatitis virus glycoprotein ...
VALENTIS, INC., The Woodlands, Texas 77381-4248. Correspondence to: Federica Pericle , VALENTIS, INC., 8301 New Trails Drive, The Woodlands, TX 77381-4248.
...
http://www.nature.com/cgt/journal/v8/n1/abs/7700270a.html...

Vical : About : Management
Dr. Rolland was Senior Vice President of Pre-Clinical Research and Development, and Head of The Woodlands Center of Valentis, Inc. from 2000 to 2002. ...
http://www.vical.com/about/management.htm...

Molecular Therapy - Abstract of article: Ligand-Dependent ...
Correspondence: Jeffrey L. Nordstrom, Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX 77381-4248. Fax: 281-364-0858. E-mail: nordsj@valentis.com ...
http://www.nature.com/mt/journal/v2/n3/abs/mt2000170a.html...

Safety toxicity study of plasmid-based IL-12 thera...[J Pharm ...
Valentis, Inc, The Woodlands, TX 77381-4248, USA. quezaa@valentis.com. We have investigated the potential toxicity of hlL-12 DNA plasmid formulated with 5% ...
http://www.ncbi.nlm.nih.gov/pubmed/11848288...

The intellectual property landscape in the field o...[J Drug ...
Technology Venturing, Valentis, Inc, The Woodlands, TX 77381, USA. Fonsm@ valentis.com. As plasmid-based gene therapy products progress through clinical
...
http://www.ncbi.nlm.nih.gov/pubmed/10758911...

Antitumoral effect of a nonviral interleukin-2 gene therapy is ...
Correspondence to: Federica Pericle, Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX 77381-4248. pericf@Valentis.com. Abstract ...
http://www.nature.com/cgt/journal/v7/n8/abs/7700216a.html...

Molecular Therapy - Abstract of article: Gene Therapy for the ...
Correspondence: Louis C. Smith, Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX 77381. Fax: (281) 364-0858. E-mail: Smithl@Valentis.com. ...
http://www.nature.com/mt/journal/v3/n4/abs/mt200178a.html...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo